|
Index of reports
> Cases with Abnormal Behaviour (11)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vyvanse (Lisdexamfetamine) where reactions include abnormal behaviour. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vyvanse side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-11
Patient: male, weighing 31.7 kg (69.8 pounds)
Reactions: Product Quality Issue, Initial Insomnia, Condition Aggravated, Abnormal Behaviour, Headache, Self Injurious Behaviour, Tremor, Affective Disorder, Mood Altered, Dizziness, Nervousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vyvanse
Possible Vyvanse side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-06
Patient: male, weighing 31.7 kg (69.8 pounds)
Reactions: Product Quality Issue, Initial Insomnia, Condition Aggravated, Abnormal Behaviour, Headache, Self Injurious Behaviour, Tremor, Affective Disorder, Mood Altered, Dizziness, Nervousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vyvanse
Possible Vyvanse side effects in 14 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22
Patient: 14 year old male, weighing 74.8 kg (164.7 pounds)
Reactions: Mania, Irritability, Agitation, Drug Ineffective, Abnormal Behaviour, Anger, Depression, Aggression
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Adderall 30
Dosage: 1 day po
Administration route: Oral
Indication: Attention Deficit / Hyperactivity Disorder
Vyvanse
Dosage: 1 day po
Administration route: Oral
Indication: Attention Deficit / Hyperactivity Disorder
Possible Vyvanse side effects in 6 year old female
Reported by a consumer/non-health professional from United States on 2012-02-23
Patient: 6 year old female
Reactions: Abnormal Behaviour, Hallucination
Drug(s) suspected as cause:
Vyvanse
Possible Vyvanse side effects in 8 year old female
Reported by a pharmacist from Canada on 2012-01-31
Patient: 8 year old female, weighing 23.0 kg (50.6 pounds)
Reactions: Grandiosity, Impulsive Behaviour, Suicidal Ideation, Speech Disorder, Physical Abuse, Hypersexuality, Anger, Self-Injurious Ideation, Condition Aggravated, Abnormal Behaviour, Verbal Abuse, Aggression, Irritability, Euphoric Mood, Insomnia, Sexual Dysfunction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vyvanse
Other drugs received by patient: Melatonin
Possible Vyvanse side effects in male
Reported by a consumer/non-health professional from United States on 2012-01-19
Patient: male, weighing 23.9 kg (52.7 pounds)
Reactions: Agitation, Dyskinesia, Abnormal Behaviour, Decreased Interest, Convulsion, Anxiety, Panic Attack, Social Avoidant Behaviour, Hallucination, Visual, Dysuria, Screaming, Mood Swings, Decreased Appetite, Crying
Drug(s) suspected as cause:
Vyvanse
Dosage: 20 mg once oral
Administration route: Oral
Indication: Attention Deficit / Hyperactivity Disorder
Start date: 2011-11-23
End date: 2011-12-20
Vyvanse
Dosage: 20 mg once oral
Administration route: Oral
Indication: Autism
Start date: 2011-11-23
End date: 2011-12-20
Possible Vyvanse side effects in male
Reported by a consumer/non-health professional from United States on 2012-01-12
Patient: male
Reactions: Weight Increased, TIC, Abnormal Behaviour
Drug(s) suspected as cause:
Vyvanse
Indication: Product Used FOR Unknown Indication
Concerta
Administration route: Oral
Indication: Attention Deficit / Hyperactivity Disorder
Unknown Multiple Medication
Indication: Product Used FOR Unknown Indication
Possible Vyvanse side effects in male
Reported by a consumer/non-health professional from United States on 2012-01-03
Patient: male, weighing 59.0 kg (129.7 pounds)
Reactions: Abnormal Behaviour, Mental Status Changes, Aggression, Suicidal Ideation, Hostility, Irritability, Psychotic Disorder, Bipolar Disorder, Expressive Language Disorder, Mental Disorder, Depression, Violence-Related Symptom, Tension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Concerta
Administration route: Oral
Start date: 2011-10-15
Concerta
Administration route: Oral
Start date: 2011-10-12
Concerta
Administration route: Oral
Start date: 2011-10-15
Concerta
Administration route: Oral
End date: 2011-09-12
Vyvanse
Start date: 2011-09-20
Concerta
Administration route: Oral
End date: 2011-09-12
Concerta
Administration route: Oral
Indication: Attention Deficit / Hyperactivity Disorder
Start date: 2011-10-13
Vyvanse
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-19
Concerta
Administration route: Oral
Start date: 2011-10-14
Concerta
Administration route: Oral
Start date: 2011-10-16
Vyvanse
Start date: 2011-09-21
Concerta
Administration route: Oral
Indication: Depression
Start date: 2011-10-13
Concerta
Administration route: Oral
Start date: 2011-10-16
Concerta
Administration route: Oral
Start date: 2011-10-12
Concerta
Administration route: Oral
Start date: 2011-10-14
Other drugs received by patient: Lithium Carbonate; Lithium Carbonate
Possible Vyvanse side effects in male
Reported by a consumer/non-health professional from United States on 2011-12-27
Patient: male, weighing 59.0 kg (129.7 pounds)
Reactions: Mental Status Changes, Abnormal Behaviour, Aggression, Suicidal Ideation, Hostility, Irritability, Psychotic Disorder, Bipolar Disorder, Expressive Language Disorder, Mental Disorder, Depression, Violence-Related Symptom, Tension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Concerta
Administration route: Oral
Start date: 2011-10-16
Concerta
Administration route: Oral
Start date: 2011-10-12
Concerta
Administration route: Oral
Start date: 2011-10-14
Concerta
Administration route: Oral
Start date: 2011-10-15
Vyvanse
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-19
Vyvanse
Start date: 2011-09-20
Concerta
Administration route: Oral
End date: 2011-09-12
Concerta
Administration route: Oral
Indication: Depression
Start date: 2011-10-13
Concerta
Administration route: Oral
End date: 2011-09-12
Concerta
Administration route: Oral
Indication: Attention Deficit / Hyperactivity Disorder
Start date: 2011-10-13
Vyvanse
Start date: 2011-09-21
Concerta
Administration route: Oral
Start date: 2011-10-12
Concerta
Administration route: Oral
Start date: 2011-10-16
Concerta
Administration route: Oral
Start date: 2011-10-15
Concerta
Administration route: Oral
Start date: 2011-10-14
Other drugs received by patient: Lithium; Lithium
Possible Vyvanse side effects in male
Reported by a consumer/non-health professional from United States on 2011-11-18
Patient: male
Reactions: Abnormal Behaviour, Drug Interaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakote
Dosage: unk, unknown
Indication: Product Used FOR Unknown Indication
Vyvanse
Dosage: unk unk, unknown
Vyvanse
Dosage: 70 mg, unknown
Indication: Product Used FOR Unknown Indication
Risperidone
Dosage: unk, unknown
Indication: Product Used FOR Unknown Indication
Possible Vyvanse side effects in 7 year old male
Reported by a physician from United States on 2011-10-06
Patient: 7 year old male, weighing 30.4 kg (66.9 pounds)
Reactions: Completed Suicide, Abnormal Behaviour, Impulsive Behaviour, Aggression
Adverse event resulted in: death
Drug(s) suspected as cause:
Symbyax
Dosage: 3mg/25mg (1 in 1 d),
Indication: Aggression
Start date: 2009-03-18
End date: 2009-04-16
Symbyax
Dosage: 3mg/25mg (1 in 1 d),
Indication: Impulsive Behaviour
Start date: 2009-03-18
End date: 2009-04-16
Lexapro
Dosage: 5 mg (5 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Anxiety
Start date: 2009-02-03
End date: 2009-03-18
Vyvanse
Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Affective Disorder
Start date: 2009-03-31
End date: 2009-04-16
Vyvanse
Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Attention Deficit / Hyperactivity Disorder
Start date: 2009-03-31
End date: 2009-04-16
Vyvanse
Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Affective Disorder
Start date: 2008-12-09
End date: 2009-03-30
Vyvanse
Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Attention Deficit / Hyperactivity Disorder
Start date: 2008-12-09
End date: 2009-03-30
|
